These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19615288)
61. [A randomized control clinical trial of Euruikang (docetaxel) in treatment of advanced non-small cell lung cancer (NSCLC)]. Cao Y; Wang ZQ; Guo Y; Feng FY; Hu XH; Xiong JP; Tang GD; Guan ZZ; Zhang L Ai Zheng; 2006 Aug; 25(8):999-1002. PubMed ID: 16965682 [TBL] [Abstract][Full Text] [Related]
62. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials. Xiao Z; Jiang Y; Wang CQ; Hu SS; Huang XR; Chen XF; Huang J; Shan LJ; Tang YH; Wang YH; Gong QH; Feng JH; Xiao X; Li XF Pharmacol Res; 2020 Mar; 153():104637. PubMed ID: 31935454 [TBL] [Abstract][Full Text] [Related]
63. Etoposide-cisplatin alternating with vinorelbine-cisplatin versus etoposide-cisplatin alone in patients with extensive disease combined with small cell lung cancer. Zhang J; Qi HW; Zheng H; Chen M; Zhu J; Xie HK; Ni J; Xu JF; Zhou CC Asian Pac J Cancer Prev; 2014; 15(10):4159-63. PubMed ID: 24935363 [TBL] [Abstract][Full Text] [Related]
64. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis. An J; Lv W Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575 [TBL] [Abstract][Full Text] [Related]
65. Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer. Liu ZJ; Wang J; Wei XY; Chen P; Wang LC; Lin L; Sun BC; Li K J Cancer Res Clin Oncol; 2012 Jun; 138(6):927-37. PubMed ID: 22331237 [TBL] [Abstract][Full Text] [Related]
66. [Circulating endothelial cells in the peripheral blood of advanced NSCLC patients]. Huang C; Li K; Wei XY; Niu RF; Sun Y; Wang JW; Zhu YZ; Xu LY; Liu XQ; Gao HJ; Zhou JM; Wang XW Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):780-3. PubMed ID: 17366796 [TBL] [Abstract][Full Text] [Related]
67. [Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy]. Long SQ; Liao GY; He WF; Wang B; Deng H; Zhang HB; Chai XS; Cai JZ; Wu WY Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2090-2. PubMed ID: 22200721 [TBL] [Abstract][Full Text] [Related]
68. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. Xu ZY; Jin CJ; Zhou CC; Wang ZQ; Zhou WD; Deng HB; Zhang M; Su W; Cai XY J Cancer Res Clin Oncol; 2011 Jul; 137(7):1117-22. PubMed ID: 21298288 [TBL] [Abstract][Full Text] [Related]
69. The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer. Myerson JS; Faria A; Puglisi M; Starling N; Popat S; O'Brien ME Lung Cancer; 2010 Sep; 69(3):365-6. PubMed ID: 20655614 [No Abstract] [Full Text] [Related]
70. Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung Cancer. Wang X; Zhang H; Zhou L; Ou H; Liu H Cancer Biother Radiopharm; 2023 Jun; 38(5):313-321. PubMed ID: 33332223 [No Abstract] [Full Text] [Related]
71. Phase II trial of mitoxantrone and cisplatin in advanced non-small-cell lung cancer. Feun LG; Savaraj N; Solomon J; Liebmann A; Hurley J Am J Clin Oncol; 1996 Apr; 19(2):190-2. PubMed ID: 8610648 [TBL] [Abstract][Full Text] [Related]
72. Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group study. Chapman R; Crowley J; Lucas JG; Hom BL; Livingston RB; Vaughn CB; Hynes HE Invest New Drugs; 1993 Feb; 11(1):91-2. PubMed ID: 8394299 [No Abstract] [Full Text] [Related]
73. Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer. Harada G; Neffa MFBV; Bonadio RC; Mendoza EZ; Caparica R; Lauricella LL; Takagaki TY; Roitberg FSR; Terra RM; Castro G J Bras Pneumol; 2021; 47(3):e20200378. PubMed ID: 33656100 [TBL] [Abstract][Full Text] [Related]
74. A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLC. Luo H; Zheng W; Yan Q; Wang B; Ye B; Deng S; He F; Yang X; Wang X Medicine (Baltimore); 2020 Jul; 99(31):e20500. PubMed ID: 32756075 [TBL] [Abstract][Full Text] [Related]
75. [The effect of amino acid nutritional support on serum tryptophan and melatonin in lung cancer patients receiving chemotherapy]. Yin S; Hu SL; Shen G; Wang WD; Hu B; Xu WP; Wang H; Zhang Q Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):840-3. PubMed ID: 17416006 [TBL] [Abstract][Full Text] [Related]
76. A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931. Herndon JE; Fleishman S; Kosty MP; Green MR Control Clin Trials; 1997 Aug; 18(4):286-300. PubMed ID: 9257067 [TBL] [Abstract][Full Text] [Related]
77. Circulating endothelial cells and tumor blood volume as predictors in lung cancer. Wang J; Xiao J; Wei X; Wang L; Lin L; Liu Z; Wang X; Sun B; Li K Cancer Sci; 2013 Apr; 104(4):445-52. PubMed ID: 23298271 [TBL] [Abstract][Full Text] [Related]
78. [Antineoplastic drug-induced extravasation]. de Wit M Med Klin (Munich); 2010 Nov; 105(11):812-24. PubMed ID: 21136240 [No Abstract] [Full Text] [Related]
79. Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Yan HA; Shen K; Huang XE Asian Pac J Cancer Prev; 2013; 14(8):4801-4. PubMed ID: 24083747 [TBL] [Abstract][Full Text] [Related]
80. Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial. Xiao Z; Chen Z; Han R; Lu L; Li Z; Lin J; Hu L; Huang X; Lin L Medicine (Baltimore); 2021 May; 100(18):e25690. PubMed ID: 33950949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]